# Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease

> **NCT06570928** · PHASE2 · COMPLETED · sponsor: **Federal University of Latin American Integration** · enrollment: 72 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** Cannabis
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06570928
- **Lead sponsor:** Federal University of Latin American Integration
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-13
- **Primary completion:** 2024-08-27
- **Final completion:** 2025-03-27
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06570928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06570928, "Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06570928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*